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Available online 14 November 2015Background: Pancreatitis is a highly prevalent medical condition associated with a spectrum of endocrine and
exocrine pancreatic insufﬁciencies. While high alcohol consumption is an established risk factor for pancreatitis,
its relationship with speciﬁc types of pancreatitis and a potential threshold have not been systematically examined.
Methods:We conducted a systematic literature search for studies on the association between alcohol consumption
and pancreatitis based on PRISMA guidelines. Non-linear and linear random-effect dose–response meta-analyses
using restricted cubic spline meta-regressions and categorical meta-analyses in relation to abstainers
were conducted.
Findings: Seven studies with 157,026 participants and 3618 cases of pancreatitis were included into analyses. The
dose–response relationship between average volume of alcohol consumption and risk of pancreatitiswasmonoton-
ic with no evidence of non-linearity for chronic pancreatitis (CP) for both sexes (p= 0.091) and acute pancreatitis
(AP) in men (p = 0.396); it was non-linear for AP in women (p = 0.008). Compared to abstention, there was a
signiﬁcant decrease in risk (RR = 0.76, 95%CI: 0.60–0.97) of AP in women below the threshold of 40 g/day. No
such association was found in men (RR = 1.1, 95%CI: 0.69–1.74). The RR for CP at 100 g/day was 6.29 (95%CI:
3.04–13.02).
Interpretation: The dose–response relationships between alcohol consumption and risk of pancreatitis were
monotonic for CP and AP in men, and non-linear for AP in women. Alcohol consumption below 40 g/day was
associated with reduced risk of AP in women. Alcohol consumption beyond this level was increasingly detrimental
for any type of pancreatitis.
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Meta-analysis1. Introduction
Pancreatitis is a prevalent inﬂammatory disorder of the pancreas
that is associatedwith highmortality and is a source of signiﬁcant global
socioeconomic burden. (Lankisch et al., 2015; Yadav and Lowenfels,
2013) The annual incidence of acute pancreatitis (AP) ranges from 13
to 45 per 100,000 population (Lankisch et al., 2015), mainly based on
studies from high-income countries. Among patients treated in US
hospitals in 2009, AP was the most frequent discharge diagnosis in
gastrointestinal disease and hepatology, the second highest cause ofnd Mental Health, Social and
reet, T519, Toronto, Ontario
mokhvalov).
. This is an open access article underall hospital stays, the largest contributor to aggregate costs, and the
ﬁfth leading cause of in-hospital deaths (Lankisch et al., 2015; Peery
et al., 2012). Chronic pancreatitis (CP) leads to progressive replacement
of pancreatic parenchymawith ﬁbrotic tissue (Braganza et al., 2011). CP
is less prevalent than AP, with annual prevalence rates ranging between
5 and 12 per 100,000 (Yadav and Lowenfels, 2013; Braganza et al.,
2011). CP is associated with a spectrum of chronic endocrine and
exocrine pancreatic insufﬁciencies, manifesting in malnutrition, diabetes
mellitus, disability, medical costs, and quality of life loss (Yadav and
Lowenfels, 2013; Braganza et al., 2011).
Alcohol consumption is considered one of the major causative
agents for pancreatitis (Lankisch et al., 2015; Irving et al., 2009); after
gallstones, alcohol is the second major leading cause of AP and the
most common cause of CP (Yadav and Lowenfels, 2013; Yadav and
Lowenfels, 2006). In 2009, a systematic review and meta-analysis onthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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et al., 2009), based on data from six studies, found a monotonically in-
creasing dose–response relationship between average alcohol
consumption and pancreatitis. Since then, a number of original studies
were published (Kume et al., 2015; Gonzalez-Perez et al., 2010; Yang
et al., 2014; Lai et al., 2011; Lembke et al., 2011; Lin et al., 2014)
which have led to recent summaries on etiological and pathobiological
aspects of different subtypes of pancreatitis (Lankisch et al., 2015;
Yadav and Lowenfels, 2013), which allow for more in-depth analyses
of the risk relationships. In particular, these new studies allow for differ-
entiation of dose–response relationships by type of pancreatitis (acute
vs. chronic) and by sex. This differentiation is important, as the biolog-
ical mechanisms underlying are different — gallstones are the primary
cause of AP, along with factors associated with biliary disease and
choledocholithiasis, such as obesity and hypertriglyceridemia, whereas
they play a negligible role in CP, except in cases where AP progresses into
CP (Yadav and Lowenfels, 2013). On the other hand, CP is associated
primarily with the impact of chronic toxic inﬂuences that makes alcohol
use the most common causative agent for CP (Yadav and Lowenfels,
2013). Consequently, while AP and CP are still seen on a continuum of
clinical manifestations of one inﬂammatory disease (Whitcomb, 2004;
Mitchell et al., 2003), the progression and outcomes of CP and AP signiﬁ-
cantly differ (Lankisch et al., 2015; Yadav and Lowenfels, 2013).
The dose–response relationships between alcohol and chronic
disease typically vary by sex, with women experiencing higher risks at
comparatively lower levels of intake (Shield et al., 2013) due to different
absorption and metabolism of alcohol (Mumenthaler et al., 1999). New
studieswill also allow for determining a threshold for alcohol consump-
tion associated with the risk of pancreatitis.
Thus, the goal of the present systematic review and series of meta-
analyses was to examine the association between alcohol consumption
and risk of different types of pancreatitis (acute and chronic) by sex,
including but not limited to analyses of potential threshold effects.
2. Methods
2.1. Literature Search Strategy
Following the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines (Moher et al., 2009),we performed
a search of OVIDMedline, Embase, PsycINFO, PubMed, Scopus andWeb
of Science databases to identify epidemiological studies that contained
information on the association between alcohol consumption and
pancreatitis. The search was conducted using a combination of alcohol
consumption related terms (“ethanol*”, “alcohol*”, “drink*”) and the
term “pancreat*” as subject terms (descriptors). As our previous search
ended in early 2009, the timeframe of this search was set between
January 2009 and May 2015. In addition, we manually searched the
content pages of themajor epidemiological journals in the ﬁeld, reference
lists of relevant articles and recent reviews. No language restrictionswere
applied.
2.2. Study Eligibility Criteria
To be included into the meta-analyses, primary studies had to:
1) be of cohort or case–control study design; 2) have a control
group of abstainers; 3) report relative risks (RR), odds ratios (OR),
hazard ratios (HR), or contain data sufﬁcient for their calculation;
4) have acute or chronic pancreatitis as an endpoint; and 5) include
two or more categories of level of alcohol consumption in comparison
to abstainers. We excluded studies if they: 1) were of cross-sectional
design; 2) did not have enough information to calculate a risk
estimate; 3) reported only on alcoholic pancreatitis (alcohol-induced
acute or chronic pancreatitis, K85.2 or K86.0); and 4) were not
published as full reports (e.g. conference abstracts) or contained partial
or incomplete data.2.3. Pancreatitis Ascertainment
Diagnoses of acute (AP) or chronic pancreatitis (CP) were deﬁned
using the International Classiﬁcation of Disease (ICD) codes reported in
the studies. Based on the study timeframe, we used the ICD-10 codes
(K85.x for acute pancreatitis of various etiologies, K86.x for chronic pan-
creatitis). For earlier studies, the corresponding ICD-8 and ICD-9 codes
were used (577.0 and 577.1 for AP and CP).
2.4. Data Extraction
Data extracted from each study included name of the ﬁrst author,
date of publication, timeframe of the study, design of the study, duration
of follow-up for cohort studies, exposuremeasures, number of observed
pancreatitis cases among participants by drinking group, number of
total participants by drinking group, study endpoints, measures of asso-
ciation (RR, HR, OR) and corresponding 95% conﬁdence intervals for
each category of alcohol consumption, while adjusting for potential
confounders. We converted alcohol intake into average grams of pure
alcohol per day (g/day) using themidpoints (mean) of reported drinking
group categories. Themidpoint for open-ended categorieswas calculated
by adding 75% of the preceding category's range to the lower bound of
the open-ended category. We used reported conversion factors when
standard drinks were the unit of measurement. Depending on the
country, one standard drink is approximately 8–14 g of pure alcohol
(World Health Organization, 2000). Assessments of full-text articles
with uncertain eligibility and data abstraction were conducted indepen-
dently by AVS and MR. Two authors discussed differences until consen-
sus was reached.
2.5. Data Analysis
We gave priority to estimates where 1) lifetime abstainers were the
risk reference group; 2) data were adjusted for potential confounders;
and 3) data were sex-speciﬁc. If necessary, risk estimates within studies
were re-calculated based on the method described by Hamling et al.
(2008) or combined using ﬁxed-effect models to derive one estimate
for each analysis per study. Each case of pancreatitis was used only
once in each of the analyses conducted.
Using studies that reported data for two or more drinking groups
with current alcohol intake (midpoints of categories) in relation to
abstainers,we conducted the two-stage restricted cubic spline regression
(three knots) in multivariable meta-regression models, taking into
account the variance–covariance matrix for multiple risk estimates
derived from one reference group to calculate non-linear dose–response
curves for average alcohol consumption (g/day) using the two-step
approach described by Orsini and colleagues (Orsini and Greenland,
2006; Orsini et al., 2012). Evidence for non-linearity was determined by
the signiﬁcance level of the second meta-regression coefﬁcient.
When no evidence for non-linearity was found, we conducted linear
two-stagemeta-regressions (Hamling et al., 2008; Orsini and Greenland,
2006).
To determine potential threshold effects, we conducted categorical
meta-analyses on the relationship between alcohol consumption
(cut-points deﬁned by 20 g/day intervals). Risk estimates were
pooled with inverse-variance weighting using DerSimonian–Laird
random-effect models to allow for between-study heterogeneity
(DerSimonian and Laird, 1986). Variation in the effect size because
of heterogeneity between studies was quantiﬁed using the Q- and
I-statistics (Yadav and Lowenfels, 2013; Higgins and Thompson,
2002). Publication bias were examined using Egger's regression-based
test (Egger et al., 1997). All meta-analytical procedureswere conducted
on the log scale in Stata statistical software, version 13.1; p b 0.05
(two-sided) was considered statistically signiﬁcant.
Most quality scores are tailored for meta-analyses of randomized
trials of interventions (Moher et al., 1998; Chalmers et al., 1981; Detsky
1998 A.V. Samokhvalov et al. / EBioMedicine 2 (2015) 1996–2002et al., 1992; Greenland and O'Rourke, 2001) and many criteria do not
apply to epidemiological studies examined in this study. Additionally,
quality score used in meta-analyses remains controversial (Greenland
andO'Rourke, 2001; Herbison et al., 2006). As a result, quality assessment
was incorporated by including quality components, such asmeasurement
of alcohol consumption and ascertainment of pancreatitis, in the inclusion
and exclusion criteria, and further by investigating potential heterogene-
ity in several subgroup analyses outlined above.
2.6. Ethics
Data were derived from published articles with anonymized data.
No ethics board review and approval were required.
3. Results
3.1. Search Results
The search identiﬁed 1823 unique articles (excluding duplicates),
six additional articles were taken from the previous meta-analysis,
and ﬁve more were identiﬁed manually. Of these, 1757 were excludedTable 1
Characteristics of the 7 articles included in the meta-analysis.
Reference Design, sex, place,
timeframe
Setting, follow-up,
participants
Eligibility criteria
Blomgren et al.
(2002)
Case–control, M/F,
Sweden, 1995–1998
Population-based.
462 cases; 1781
controls
Age 20–95, both sexes; exclud
those who didn't have access
telephone or were not able to
speak Swedish, had history o
malignancies, previous AP/CP
those hospitalized for ≥30 da
Lin et al. (2001) Case–control, M,
Japan, 1997–1998
Hospital-based.
91 cases, 175
controls
Excluded those who failed to
return the study questionnair
Morton et al.
(2004)
Cohort, M/F, US,
1978–1998
Population-based.
439 cases;
128,495 controls
Prepaid health plan members
able to complete research
questionnaire. Data must be
sufﬁcient to diagnose
pancreatitis.
Kristiansen et al.
(2008)
Cohort, M/F,
Denmark,
1976–2007
Population-based.
268 cases; 17,670
controls
Participants of the Copenhage
City Heart Study. Excluded
people with previously
diagnosed pancreatitis.
Yadav et al.
(2009)
Case–control, M/F,
US, 2000–2006
Hospital-based,
985 cases (CP, n =
536 and recurrent
AP, n = 449), 663
controls.
North American Pancreatitis
Study 2 (NAPS 2). Exclusion
criteria not reported.
Gonzalez-Perez
et al. (2010)
Case–control, M/F,
UK, 1996–2006
Population-based.
419 cases and
5000 controls
20–79 years of age, both sexe
who were enrolled at least 2
years with their GP, ﬁrst
prescription N1 year before
entering the study and at leas
health contact in the last 2 ye
Excluded if history cancer oth
than non-melanoma skin can
or pancreatic disease; people
who were 70+ years of age
with a FU over 1 year and les
than 2 health contacts.
Kume et al.
(2015)
Case–control, M/F,
Japan, 2005–2010
Hospital-based.
982 cases, (574
cases of AP and
574 cases of CP),
1015 controls.based on title or abstract. 77 articles were retrieved in full text for
further review. Out of these, 55 did not meet our inclusion criteria. In
total, seven studies met the inclusion criteria: two each in the United
States and Japan; and one each from the UK, Sweden, and Denmark.
Detailed descriptions of the studies included are presented in Table 1.
These studies included 157,026 participants with 3618 cases of pancre-
atitis— 2490 cases of ﬁrst episode or recurrent AP and 1128 cases of CP.
Five studies had datasets speciﬁc to AP, four studies had datasets speciﬁc
for CP. Five studies had a case–control design and twowere cohort stud-
ies (Fig. 1).
3.2. Dose–Response Relationship
Figs. 2 to 4 (see also Table 2) show the dose–response relationship
between average alcohol consumption and CP (n = 4 studies, Fig. 2),
AP among men (n = 3 studies, Fig. 3) and women (n = 3 studies,
Fig. 4). For CP, the relationship was monotonically increasing with no
evidence for non-linearity (p = 0.091) (RRs at 25 g/day = 1.58,
95%CI: 1.32–1.90; 50 g/day = 2.51, 95%CI: 1.74–3.61; 75 g/day =
3.97, 95%CI: 2.30–6.85; 100 g/day = 6.29; 95%CI: 3.04–13.02) (Fig. 3,
linearmodel). Therewere not enough data to systematically investigateAlcohol consumption categories Endpoint Adjustment
ed
to
f
, or
ys
Non-drinkers; N0–b20 g/week;
20–b120 g/week; 120–220 g/week;
220–b320 g/week; 320–b420 g/week;
420 g/week and more.
AP Unadjusted data used for
analyses
e.
Ex-Drinkers; Non-drinkers; b50 g/day;
50–99 g/day; 100+ g/day.
CP BMI, education level,
cigarette smoking.
Ex-drinkers; never drinkers; b1
drink/month; 1 drink/month–b1
drink/day; 1–2 drinks per day;
3+ drinks per day.
Any
pancreatitis
Age, sex, race, education,
marital status, BMI,
smoking.
n Non-drinkers; 1–6 drinks/week;
7–13 drinks/week; 14–20 drinks/week;
21–34 drinks/week; 35–48
drinks/week; 48+ drinks/week
Both AP
and CP
Age, sex, smoking,
education, BMI
b20 drinks in a lifetime; ≤0.5 drinks per
day or ≤3 drinks per week; 0.5–1 drinks
per day, or 4–7 drinks per week for
women, 0.5–2 drinks per day or 4–14
drinks per week for men; 1–5 drinks
per day or 8–34 drinks per week for
women and 2–5 drinks per day or
15–34 drinks per week for men; 5 or
more drinks per day or 35 or more
drinks per week.
Recurrent
AP and CP
Unadjusted data used for
analyses
s,
t 1
ars.
er
cer
s
Non-drinkers; 1–7 drinks/week; 8–29
drinks per week; 30+ drinks per week
AP Age, sex, calendar year,
BMI, Townsend deprivation
index, smoking status,
alcohol intake, general
comorbidities, and several
medication groups
(antidiabetic drugs,
antibiotics, antidepressants,
corticosteroids,
acid-suppressing drugs,
NSAIDs, antihypertensives,
lipid-lowering drugs and
HRT).
Non-drinkers; b20 g/day; 20–40 g/day;
40–60 g/day; 60–80 g/day;
80–100 g/day;
100+ g/day
Both AP
and CP
Age, sex, hospital, time to
ﬁrst hospital visit.
Fig. 1. PRISMA ﬂowchart.
1999A.V. Samokhvalov et al. / EBioMedicine 2 (2015) 1996–2002sex-speciﬁc relationships for CP. There was no evidence for non-linearity
for AP amongmen (p=0.396, Table 2) (RRs [linearmodel] at 25 g/day=
1.38, 95%CI: 1.12–1.69; 50 g/day = 1.89, 95%CI 1.25–2.86; 75 g/day =
2.60, 95%CI: 1.40–4.83; 100 g/day = 3.58, 95%CI: 1.57–8.16). Among
women, there was strong evidence for a non-linear association both for
any type of pancreatitis (p b 0.001) and AP (p= 0.008), with a potential
beneﬁcial effect of up to 40 g/day and a steep increase in risk beyond this
threshold (Fig. 4), higher than among men.
Analyses of the dose–response relationship between alcohol
consumption and the risk of CP conducted separately using the data
from different geographical areas – Asia and Europe or US – showed
that the risk of CP in Asia (n = 2) is increasing in a linear fashion with
a higher slope than in Europe or US (n = 2) (Suppl. Figs. S1–S2). Only
one study fromAsia reported the risk for AP (Kume et al., 2015) showing
a similar relationship compared to all other studies.Fig. 2. Pooled dose–response risk relationships between average alcohol consumption and
chronic pancreatitis, both sexes.Categorical meta-analyses supported these ﬁndings (Suppl. Figs.
S3–S5). The difference between men and women is highlighted by
a comparison of b40 g/day alcohol intake compared to abstention
(Fig. 5). While there was no difference among men (RR = 1.10, 95%CI:
0.69–1.74), women showed a signiﬁcantly lower risk (RR = 0.76,
95%CI: 0.60–0.97). Analyses for any pancreatitis (Table 2, Figs. S6–S7)
conﬁrmed evidence for a non-linear relationship among women and a
linear relationship among men.3.3. Heterogeneity and Publication Bias
Between-study heterogeneity was low to moderate in analyses on
AP among women, and moderate to high for CP and AP among men.
Using all studies available, there was no evidence for publication biasFig. 3. Pooled dose–response risk relationships between average alcohol consumption and
acute pancreatitis in men.
Fig. 4. Pooled dose–response risk relationships between average alcohol consumption and
acute pancreatitis in women.
2000 A.V. Samokhvalov et al. / EBioMedicine 2 (2015) 1996–2002(Egger's test, Figs. S8–S9) or single inﬂuential studies (Figs. S10–S11) for
estimates up to 40 g/day.4. Discussion
There were differential dose–response relationships between men
and women with respect to alcohol consumption, as well as type of
pancreatitis. The dose–response relationship between the level of alco-
hol consumption and CP was linear, and monotonically increasing with
no identiﬁable threshold. On the contrary, the relation between average
alcohol consumption and APwas non-linear (J-shaped) amongwomen,
and monotonically increasing among men. High alcohol consumption
was consistently associated with an increased risk for pancreatitis at
the alcohol consumption level above 40 g/day (higher than previously
reported) (Irving et al., 2009).
There are two plausible explanations for a J-shaped relationship
between alcohol consumption and AP as it appeared in women. First,
the beneﬁcial effectmay be explained by contamination of the reference
group that included ex-drinkers who quit drinking due to health prob-
lems and were at increased risk of developing pancreatitis. Two studies
reported on the risk of pancreatitis in former drinkers (Lin et al., 2001;
Morton et al., 2004). In comparison to lifetime abstainers, former
drinkers showed an elevated risk for any pancreatitis (RR = 2.20,
95%CI: 1.45–3.34), and there was no beneﬁcial association (RR = 1.01,
95%CI: 0.82–1.24) of moderate alcohol consumption (b40 g/day).Table 2
Pooled restricted cubic spline and linear regression coefﬁcients for dose–response relationship
Diagnosis/sex Model Number of studies Number of cases
Any pancreatitis
Men Spline 3 1451
Men Linear 3 1451
Women Spline 3 978
CP
Both sexes Spline 4 1128
Both sexes Linear 4 1128
AP
Both sexes Spline 6 2490
Both sexes Linear 6 2490
Men Spline 3 847
Men Linear 3 847
Women Spline 3 638
SE, standard error.There were not enough data to stratify this relationship by pancreatitis
diagnosis or sex.
The second explanation is related to the distribution of etiological
factors for different types of pancreatitis in men and women, and
accordingly, the pathogenesis and natural history of the disease. Specif-
ically, alcohol consumption is the predominant cause of CP in Western
countries, with the proportion of cases of alcoholic pancreatitis reaching
80% and sometimes even 95% (Braganza et al., 2011; Pezzilli, 2009). The
pathophysiology of CP is based on damage to acinar cells of the pancreas
(mediated by sustained elevation of the cytosolic Ca2+ levels)
(Gerasimenko et al., 2014), which start releasing synthesized pancreatic
enzymes into interstitium(pancreastasis), thus triggering inﬂammation
(Braganza et al., 2011).While a number of agents and factors can trigger
pancreastasis, it was indicated that alcohol metabolism plays a signiﬁ-
cant role in it as it is associated with the production of reactive oxygen
species (ROS) via acetaldehyde pathway (Gonzalez, 2005) and fatty
acid ethyl esters (FAEE) via non-oxidative route (Pandol and Raraty,
2007;Witt et al., 2007)which in turn cause injury to acinar cells and ac-
tivate stellate cells (Braganza et al., 2011). Since the quantities of alcohol
metabolites and their impact directly correlate with the amounts of
alcohol consumed, the relationship between alcohol consumption
level and the risk of CP is monotonic.
The interaction between alcohol and other etiological factors in
AP is quite similar to CP from pathobiological standpoint— a cascade
of intra- and extracellular reactions leads to FAEE-induced increase
of the Ca2+ release that in turn leads to necrosis of pancreatic acinar
cells (Gerasimenko et al., 2014). At the same time a more complex
interplay between variety of etiological factors is observed — alcohol is
the second leading cause of AP after gallstones and biliary problems
leading to them (Lankisch et al., 2015). It was shown that low alcohol
consumption is reducing the risk of symptomatic choledocholithiasis,
and thus lowering the risk of biliary AP (Leitzmann et al., 1999).
This hypothesis also provides some insight into more pronounced
beneﬁcial effects of low alcohol consumption on the risk of AP in
women compared tomen. Speciﬁcally, women aremore likely to develop
biliary problems and gallstones (Shen et al., 2013; Russell et al., 1998) and
therefore constitute a larger proportion of the cases of biliary AP, whereas
men are more likely to consume larger amounts of alcohol on daily basis
and to binge drink, and therefore represent the majority of cases of
alcoholic AP. Thus, the proportion of women consuming alcohol at the
levels of less than 40 g per day, which reduces their risk of biliary AP, is
higher compared tomen, and the beneﬁcial effect of low levels of alcohol
consumption is therefore more pronounced. This can be illustrated by
data from the study by Morton et al. (2004). The subset of cases of
alcoholic pancreatitis demonstrated an exponential increase of the risk
of pancreatitis with the increase of the daily alcohol consumption. At
the same time, in the subset of gallstone pancreatitis cases, the risk ofs.
Coefﬁcient 1 Coefﬁcient 2
Beta SE p Beta SE p
−0.003 0.017 0.863 0.028 0.021 0.186
0.017 0.003 b0.001 NA NA NA
−0.033 0.011 0.002 0.077 0.016 b0.001
0.007 0.009 0.427 0.014 0.008 0.091
0.018 0.004 b0.001 NA NA NA
0.003 0.009 0.771 0.017 0.013 0.201
0.011 0.002 b0.001 NA NA NA
0.0002 0.015 0.988 0.015 0.018 0.396
0.013 0.004 0.002 NA NA NA
−0.028 0.010 0.007 0.059 0.022 0.008
Fig. 5. Pooled relative risk of acute pancreatitis for 0·1–40 g/day drinking category compared to abstainers.
2001A.V. Samokhvalov et al. / EBioMedicine 2 (2015) 1996–2002pancreatitis was lower in subjects consuming low amounts of alcohol,
and increased with higher alcohol consumption.
While both sick-quitter and biliary effect hypotheses appear to be
plausible explanations, there are no data available to test and to deter-
mine their relative contribution. Further research is required here,
with speciﬁc focus on comparisons between ex-drinkers and lifetime
abstainers, and the distribution of different types of pancreatitis
depending on the alcohol consumption levels, preferably separated by
sex.
The data on the risk of pancreatitis in different populations are
scarce.While the data onAPwere not sufﬁcient to drawany conclusions
regarding the impact of ethnicity on the risk of pancreatitis we were
able to conduct separate analyses for CP based on geographical area of
the study and there are indications that the risk of CP in predominantly
Asian populations is linear and higher than in non-Asians or mixed
populations of Europe andUS. These variationsmay be related to genetic
factors (e.g. Brooks et al., 2009), different drinking patterns as well as
dietary variations.
4.1. Strengths and Limitations
Amajor strength of our study was the testing of alcohol consumption
as a non-linear risk factor for pancreatitis as a continuumof inﬂammatory
diseases of the pancreas, as well as subanalyses for speciﬁc types (acute
and chronic) of pancreatitis and for men and women. At the same time,
it must be noted that certain subgroup analyses were subject to low
power due to a limited number of studies included, and we were not
able to conduct separate analyses for men and women having CP as
well as for the studies conducted in ethnically different populations or
geographical areas. Also, there were not enough data to separate recur-
rent AP from other forms of AP, but from studies which were able to do
this separation, it seems to be justiﬁed to combine them. Also, further
research is needed to explore the impact of alcohol on the risk of pancre-
atitis in speciﬁc populations such as former drinkers; the interplay ofalcohol, diet and biliary problems in men and women; as well as the
role of alcohol in development of pancreatitis of non-alcoholic etiology.
Another potential limitation is related to the fact that alcohol con-
sumption was self-reported in all of the studies, which adds variability
to alcohol consumption estimates in that they are subject to recall bias
and other biases. Finally, our analyses are based on the data from
published studies, and thus are a subject to potential publication bias.
Though we did not ﬁnd evidence for such bias, we cannot completely
exclude such a possibility.
4.2. Implications
We have collected and systematized all the data available on the
relationship between alcohol consumption and risk of pancreatitis.
Our analyses allowed us to describe this relationship differentially for
the major types of pancreatitis in men and women. These differences
might be due to several factors, but primarily, they highlight the high
risk of heavy alcohol consumption, as well as the potentially beneﬁcial
effects of moderate intake (b40 g/day), especially among women.
These ﬁndings can be used for development of recommendations for
pancreatitis prevention. Also, we have identiﬁed several gaps in
knowledge that can guide further research.
5. Conclusions
There are differential dose–response relationships between average
volume of alcohol consumption and risk of different types of pancreatitis
inmen andwomen. The relationshipwas linear for CP and AP inmen, but
non-linear for AP in women. There was strong evidence supporting a
threshold effect for AP in women at the level of alcohol consumption of
up to 40 g/day. Beyond 40 g of pure alcohol/day, the risk of pancreatitis,
both acute and chronic, regardless of sex, was higher than previously
thought.
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